SELLAS Life Sciences Group, Inc. (SLS) Earnings
NASDAQ·Healthcare·Biotechnology
$10.25
-5.42%
Mkt Cap $2.30B
EPS — Estimate vs Actual
Mkt Cap
$2.30B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.23
NASDAQ·Healthcare·Biotechnology
$10.25
-5.42%
Mkt Cap $2.30B
Mkt Cap
$2.30B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.23